Leptin levels in menopause: Effect of estrogen replacement therapy

Rosa Maria Cento, Caterina Proto, Rosario Sebastiano Spada, Valerio Napolitano, Mario Ciampelli, Francesco Cucinelli, Antonio Lanzone

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

To evaluate the effect of menopause and estrogen replacement therapy on leptin levels, 17 white postmenopausal women were recruited for the study. After an overnight fasting, blood samples were collected for LH, FSH, estradiol, testosterone, androstenedione, DHEA sulfate, insulin and leptin assays. Body mass index (BMI) and the waist-to-hip ratio were also evaluated. Patients were reanalyzed after a 12-week administration of transdermal estrogen patches delivering 50 μg 17β-estradiol. The results were compared to those obtained from a group of 11 female volunteers in reproductive age, in whom basal blood was sampled during the early follicular phase of their cycle. Patients were divided into lean and obese according to their BMI. Obese postmenopausal women showed lower leptin levels when compared to premenopausal counterparts (25.1 ± 5.9 vs. 37 ± 11.3; p <0.05), whereas no significant differences were found between the lean groups (14.5 ± 3.8 vs. 14.4 ± 4.9). Estrogen administration did not significantly change serum leptin concentrations in hypoestrogenized women (obese: 25.1 ± 5.9 vs. 28.6 ± 9.2; lean: 14.4 ± 4.9 vs. 17.6 ± 7.2). A positive linear correlation was found between leptin plasma levels and BMI only in obese patients (r = 0.58; p <0.01) both before and after estrogen treatment. Menopause is characterized by a decreased expression of the obese gene, even if estrogens do not seem to represent a main causal factor. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)269-273
Number of pages5
JournalHormone Research
Volume52
Issue number6
Publication statusPublished - 1999

Fingerprint

Estrogen Replacement Therapy
Menopause
Leptin
Estrogens
Body Mass Index
Estradiol
Transdermal Patch
Dehydroepiandrosterone Sulfate
Follicular Phase
Waist-Hip Ratio
Androstenedione
Testosterone
Volunteers
Fasting
Insulin
Gene Expression
Serum

Keywords

  • Estrogen replacement
  • Leptin
  • Menopause
  • Obesity
  • Reproductive age

ASJC Scopus subject areas

  • Endocrinology

Cite this

Cento, R. M., Proto, C., Spada, R. S., Napolitano, V., Ciampelli, M., Cucinelli, F., & Lanzone, A. (1999). Leptin levels in menopause: Effect of estrogen replacement therapy. Hormone Research, 52(6), 269-273.

Leptin levels in menopause : Effect of estrogen replacement therapy. / Cento, Rosa Maria; Proto, Caterina; Spada, Rosario Sebastiano; Napolitano, Valerio; Ciampelli, Mario; Cucinelli, Francesco; Lanzone, Antonio.

In: Hormone Research, Vol. 52, No. 6, 1999, p. 269-273.

Research output: Contribution to journalArticle

Cento, RM, Proto, C, Spada, RS, Napolitano, V, Ciampelli, M, Cucinelli, F & Lanzone, A 1999, 'Leptin levels in menopause: Effect of estrogen replacement therapy', Hormone Research, vol. 52, no. 6, pp. 269-273.
Cento RM, Proto C, Spada RS, Napolitano V, Ciampelli M, Cucinelli F et al. Leptin levels in menopause: Effect of estrogen replacement therapy. Hormone Research. 1999;52(6):269-273.
Cento, Rosa Maria ; Proto, Caterina ; Spada, Rosario Sebastiano ; Napolitano, Valerio ; Ciampelli, Mario ; Cucinelli, Francesco ; Lanzone, Antonio. / Leptin levels in menopause : Effect of estrogen replacement therapy. In: Hormone Research. 1999 ; Vol. 52, No. 6. pp. 269-273.
@article{47750b152e0446deaf46e7ca8ce4e219,
title = "Leptin levels in menopause: Effect of estrogen replacement therapy",
abstract = "To evaluate the effect of menopause and estrogen replacement therapy on leptin levels, 17 white postmenopausal women were recruited for the study. After an overnight fasting, blood samples were collected for LH, FSH, estradiol, testosterone, androstenedione, DHEA sulfate, insulin and leptin assays. Body mass index (BMI) and the waist-to-hip ratio were also evaluated. Patients were reanalyzed after a 12-week administration of transdermal estrogen patches delivering 50 μg 17β-estradiol. The results were compared to those obtained from a group of 11 female volunteers in reproductive age, in whom basal blood was sampled during the early follicular phase of their cycle. Patients were divided into lean and obese according to their BMI. Obese postmenopausal women showed lower leptin levels when compared to premenopausal counterparts (25.1 ± 5.9 vs. 37 ± 11.3; p <0.05), whereas no significant differences were found between the lean groups (14.5 ± 3.8 vs. 14.4 ± 4.9). Estrogen administration did not significantly change serum leptin concentrations in hypoestrogenized women (obese: 25.1 ± 5.9 vs. 28.6 ± 9.2; lean: 14.4 ± 4.9 vs. 17.6 ± 7.2). A positive linear correlation was found between leptin plasma levels and BMI only in obese patients (r = 0.58; p <0.01) both before and after estrogen treatment. Menopause is characterized by a decreased expression of the obese gene, even if estrogens do not seem to represent a main causal factor. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Estrogen replacement, Leptin, Menopause, Obesity, Reproductive age",
author = "Cento, {Rosa Maria} and Caterina Proto and Spada, {Rosario Sebastiano} and Valerio Napolitano and Mario Ciampelli and Francesco Cucinelli and Antonio Lanzone",
year = "1999",
language = "English",
volume = "52",
pages = "269--273",
journal = "Hormone Research",
issn = "0301-0163",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Leptin levels in menopause

T2 - Effect of estrogen replacement therapy

AU - Cento, Rosa Maria

AU - Proto, Caterina

AU - Spada, Rosario Sebastiano

AU - Napolitano, Valerio

AU - Ciampelli, Mario

AU - Cucinelli, Francesco

AU - Lanzone, Antonio

PY - 1999

Y1 - 1999

N2 - To evaluate the effect of menopause and estrogen replacement therapy on leptin levels, 17 white postmenopausal women were recruited for the study. After an overnight fasting, blood samples were collected for LH, FSH, estradiol, testosterone, androstenedione, DHEA sulfate, insulin and leptin assays. Body mass index (BMI) and the waist-to-hip ratio were also evaluated. Patients were reanalyzed after a 12-week administration of transdermal estrogen patches delivering 50 μg 17β-estradiol. The results were compared to those obtained from a group of 11 female volunteers in reproductive age, in whom basal blood was sampled during the early follicular phase of their cycle. Patients were divided into lean and obese according to their BMI. Obese postmenopausal women showed lower leptin levels when compared to premenopausal counterparts (25.1 ± 5.9 vs. 37 ± 11.3; p <0.05), whereas no significant differences were found between the lean groups (14.5 ± 3.8 vs. 14.4 ± 4.9). Estrogen administration did not significantly change serum leptin concentrations in hypoestrogenized women (obese: 25.1 ± 5.9 vs. 28.6 ± 9.2; lean: 14.4 ± 4.9 vs. 17.6 ± 7.2). A positive linear correlation was found between leptin plasma levels and BMI only in obese patients (r = 0.58; p <0.01) both before and after estrogen treatment. Menopause is characterized by a decreased expression of the obese gene, even if estrogens do not seem to represent a main causal factor. Copyright (C) 2000 S. Karger AG, Basel.

AB - To evaluate the effect of menopause and estrogen replacement therapy on leptin levels, 17 white postmenopausal women were recruited for the study. After an overnight fasting, blood samples were collected for LH, FSH, estradiol, testosterone, androstenedione, DHEA sulfate, insulin and leptin assays. Body mass index (BMI) and the waist-to-hip ratio were also evaluated. Patients were reanalyzed after a 12-week administration of transdermal estrogen patches delivering 50 μg 17β-estradiol. The results were compared to those obtained from a group of 11 female volunteers in reproductive age, in whom basal blood was sampled during the early follicular phase of their cycle. Patients were divided into lean and obese according to their BMI. Obese postmenopausal women showed lower leptin levels when compared to premenopausal counterparts (25.1 ± 5.9 vs. 37 ± 11.3; p <0.05), whereas no significant differences were found between the lean groups (14.5 ± 3.8 vs. 14.4 ± 4.9). Estrogen administration did not significantly change serum leptin concentrations in hypoestrogenized women (obese: 25.1 ± 5.9 vs. 28.6 ± 9.2; lean: 14.4 ± 4.9 vs. 17.6 ± 7.2). A positive linear correlation was found between leptin plasma levels and BMI only in obese patients (r = 0.58; p <0.01) both before and after estrogen treatment. Menopause is characterized by a decreased expression of the obese gene, even if estrogens do not seem to represent a main causal factor. Copyright (C) 2000 S. Karger AG, Basel.

KW - Estrogen replacement

KW - Leptin

KW - Menopause

KW - Obesity

KW - Reproductive age

UR - http://www.scopus.com/inward/record.url?scp=0033362104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033362104&partnerID=8YFLogxK

M3 - Article

C2 - 10965205

AN - SCOPUS:0033362104

VL - 52

SP - 269

EP - 273

JO - Hormone Research

JF - Hormone Research

SN - 0301-0163

IS - 6

ER -